Michelle Grimard

Statistics

Publications

Citations

272

H-Index

Active since

2016

Affiliations

Indiana University – Purdue University Indianapolis(Current)

Indiana University School of Medicine

Purdue University West Lafayette

Michelle Grimard is an author at Indiana University – Purdue University Indianapolis specializing in cancer cell signaling, oncogenic signaling pathways, and oncology.

Publications per year

2016–2021

Publications

Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer Models

Derek P. Logsdon, Michelle Grimard, Meihua Luo et al. · Molecular Cancer Therapeutics · 2016 · 113 citations · Full text

Medicine, Molecular Biology, Oncology +17

<scp>APE</scp>1/Ref‐1 knockdown in pancreatic ductal adenocarcinoma – characterizing gene expression changes and identifying novel pathways using single‐cell<scp>RNA</scp>sequencing

Fenil Shah, Emery Goossens, Michelle Grimard et al. · Molecular Oncology · 2017 · 41 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Applying Small Molecule Signal Transducer and Activator of Transcription-3 (STAT3) Protein Inhibitors as Pancreatic Cancer Therapeutics

Carolyn C. Arpin, Stephen Mac, Yanlin Jiang et al. · Molecular Cancer Therapeutics · 2016 · 39 citations · Full text

Medicine, Oncology, Pharmacology +17

Identification and Characterization of AES-135, a Hydroxamic Acid-Based HDAC Inhibitor That Prolongs Survival in an Orthotopic Mouse Model of Pancreatic Cancer

Andrew E. Shouksmith, Fenil Shah, Michelle Grimard et al. · Journal of Medicinal Chemistry · 2019 · 37 citations · Full text

Medicine, Oncology, Pharmacology +10

Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours

Silpa Gampala, Fenil Shah, Chi Zhang et al. · British Journal of Cancer · 2021 · 26 citations · Full text

Medicine, Cancer Biology, Oncology +16

1–5 of 6